Drug details

Dutrebis (lamivudine and raltegravir film-coated tablets)

type of HIV, ART Combos

Dutrebis (lamivudine and raltegravir) is a combination HIV-1 nucleoside analogue reverse transcriptase inhibitor and a human immunodeficiency virus integrase strand transfer inhibitor used in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection.

The drug is often used to treat HIV .

This drug may have the following side effects:
  • hives,
  • difficulty breathing,
  • swelling of your face, lips, tongue, or throat,
  • nausea,
  • loss of appetite,
  • dark urine,
  • rash,
  • vomiting,
  • diarrhea,
  • fever,
  • swollen glands,
  • night sweats,
  • shortness of breath,
  • weight loss,
  • body aches,
  • tiredness,
  • stomach pain,
  • clay-colored stools,
  • yellowing of the skin or eyes (jaundice),
  • dizziness,
  • wheezing,
  • weakness,
  • cough,
  • sore throat,
  • stomach pain (upper right side),
  • menstrual changes, and
  • extreme tiredness,
  • feeling cold,
  • eye redness,
  • general ill feeling,
  • cold sores,
  • trouble speaking or swallowing,
  • problems with balance or eye movement,
  • swelling in your neck or throat (enlarged thyroid),
  • impotence
  • unusual muscle pain,
  • prickly feeling,
  • irregular heart rate,
  • skin blisters or peeling,
  • swelling around your abdomen,
The following drugs are related to Dutrebis, either as a replacement or used together:
  • Ziagen (abacavir sulfate)
  • Trizivir (abacavir sulfate, lamivudine, and zidovudine)
  • Agenerase Capsules (amprenavir capsules)
  • Agenerase Oral Solution (amprenavir oral solution)
  • Evotaz (atazanavir and cobicistat tablets for oral administration)
  • Combivir (lamivudine, zidovudine)
  • Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate tablets)
  • Rescriptor (delavirdine mesylate)
  • Sustiva (efavirenz)
  • Egrifta (tesamorelin injection)
  • Vitekta (elvitegravir tablets)
  • Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir df)
  • Epivir (lamivudine)
  • Viracept (nelfinavir mesylate)
  • Viramune (nevirapine)
  • Viramune XR (nevirapine extended-release tablets, for oral use)
  • Retrovir (zidovudine)
  • Retrovir IV (zidovudine injection)